Docusate Sodium
- Product NDC
- 50804-862
- 11-digit product format
- 508040862
- Labeler code
- 50804
- Product ID
- 50804-862_35723d9b-5731-4dba-86c5-fd846178a207
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- DOCUSATE SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Good Sense (Geiss, Destin & Dunn, Inc.)
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-05-28
- Marketing end
- 2026-05-28
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Current FDA listing
- Yes
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50804-862 | DOCUSATE SODIUM CAPSULE [GOOD SENSE (GEISS, DESTIN & DUNN, INC.)] | 4 | Current NDC, Legacy NDC | 20240404_d729ceac-2eef-40c0-bb1a-f8d80290c60f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50804-862-25 | 50804086225 | 25 CAPSULE in 1 BOTTLE, PLASTIC (50804-862-25) | 25 capsule | 2021-05-28 | 2026-05-28 | No | No | Current |